Retatrutide 10mg

Retatrutide 10mg

Retatrutide is a next-generation triple agonist peptide targeting GLP-1, GIP, and glucagon receptors simultaneously. Each vial contains 10mg of high-purity Retatrutide, making it one of the most potent metabolic research peptides available.

Metabolic & Weight Research

• Supports research into body weight reduction via triple receptor agonism
• Assists in studies on appetite suppression and satiety signalling
• Promotes research into fat mass reduction and adipose tissue metabolism
• Supports glucagon-mediated energy expenditure and thermogenesis research
• Aids in lipid metabolism and triglyceride reduction studies
• Supports research into lean mass preservation during caloric deficit and fat loss
• Assists in body composition studies examining fat loss with muscle retention

Glycaemic & Metabolic Research

• Supports GLP-1 and GIP receptor-mediated insulin secretion research
• Assists in blood glucose regulation and insulin sensitivity studies
• Promotes research into type 2 diabetes and metabolic syndrome pathways
• Supports pancreatic beta cell function and preservation research
• Aids in hepatic glucose output and liver metabolism studies

Additional Research Areas

• Non-alcoholic fatty liver disease (NAFLD) pathway studies
• Hormonal regulation and endocrine system research
• Comparative efficacy studies vs GLP-1 single agonists

For research purposes only. Not for human consumption.